These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15172836)

  • 1. The critical micelle concentrations of lysophosphatidic acid and sphingosylphosphorylcholine.
    Li Z; Mintzer E; Bittman R
    Chem Phys Lipids; 2004 Jul; 130(2):197-201. PubMed ID: 15172836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
    Kostenis E
    J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.
    Jalink K; Hengeveld T; Mulder S; Postma FR; Simon MF; Chap H; van der Marel GA; van Boom JH; van Blitterswijk WJ; Moolenaar WH
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):609-16. PubMed ID: 7733903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
    Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lysophospholipids on signaling in the human Jurkat T cell line.
    Xu Y; Casey G; Mills GB
    J Cell Physiol; 1995 Jun; 163(3):441-50. PubMed ID: 7775587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface adsorption of zwitterionic surfactants: n-alkyl phosphocholines characterised by surface tensiometry and neutron reflection.
    Yaseen M; Wang Y; Su TJ; Lu JR
    J Colloid Interface Sci; 2005 Aug; 288(2):361-70. PubMed ID: 15927600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.
    Spangelo BL; Jarvis WD
    Endocrinology; 1996 Oct; 137(10):4419-26. PubMed ID: 8828503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
    Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
    Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel carbonyl and nitrile products from reactive chlorinating species attack of lysosphingolipid.
    Brahmbhatt VV; Hsu FF; Kao JL; Frank EC; Ford DA
    Chem Phys Lipids; 2007 Feb; 145(2):72-84. PubMed ID: 17126823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine, sphingosylphosphorylcholine and sphingosine 1-phosphate modulate phosphatidylserine homeostasis in glioma C6 cells.
    Wójcik M; Barańska J
    Acta Biochim Pol; 1999; 46(1):125-31. PubMed ID: 10453988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells.
    Chen PF; Chin TY; Chueh SH
    Kidney Int; 1998 Nov; 54(5):1470-83. PubMed ID: 9844123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery.
    Choi SK; Ahn DS; Lee YH
    Cardiovasc Res; 2009 May; 82(2):324-32. PubMed ID: 19218288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosylphosphorylcholine as a novel calmodulin inhibitor.
    Kovacs E; Liliom K
    Biochem J; 2008 Mar; 410(2):427-37. PubMed ID: 17979830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytosolic protein phosphorylation by sphingosylphosphorylcholine.
    Pushkareva MYu ; Hannun YA
    Biochim Biophys Acta; 1994 Mar; 1221(1):54-60. PubMed ID: 8130276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cytochrome c with 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine: evidence for acyl chain reversal.
    Mattila JP; Sabatini K; Kinnunen PK
    Langmuir; 2008 Apr; 24(8):4157-60. PubMed ID: 18315024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
    Lyons JM; Karin NJ
    J Bone Miner Res; 2001 Nov; 16(11):2035-42. PubMed ID: 11697799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.
    Okamoto H; Takuwa N; Yatomi Y; Gonda K; Shigematsu H; Takuwa Y
    Biochem Biophys Res Commun; 1999 Jun; 260(1):203-8. PubMed ID: 10381367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.